Speaker
Senior Vice President, Business Development, Orum Therapeutics, Inc.
Greg Dwyer, Senior Vice President, Business Development at Orum Therapeutics, Inc., spoke at Oncology & Immunology Innovation Partnering & Licensing Summit (Boston, United States of America, 9–10 Sept 2026) in the session “Increasing the Therapeutic Index of a Small Molecule as Precision ADCs: What Have we Learnt so Far?”.
9–10 Sept 2026Boston, United States of America
Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co
Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo
Science Partner, Flagship Pioneering
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca
Co-Founder & Chief Technology Officer, Sibylla Biotech srl
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Greg Dwyer, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].